文献速递乳腺外科围术期管理与 ERAS

70岁及以上女性乳房切除后重建:NCDB分析

Postmastectomy breast reconstruction in women aged 70 and older: An analysis of the National Cancer Database (NCDB).
PubMed 文献 · Surgery · 2021-04-20

该研究基于美国国家癌症数据库(NCDB)2004至2015年数据,纳入73973例70岁及以上接受乳房切除术的乳腺癌患者,其中4552例(6.1%)行乳房切除后重建(PMBR)。重建类型以假体为主(48%),自体组织重建占36.2%,联合重建占15.1%。PMBR患者30天再入院率较高(3.5% vs 2.8%,P<.001),但30天和90天死亡率更低(0.03%和0.2% vs 0.3%和0.9%,P<.001)。

要点

  • 70岁及以上乳腺癌患者中仅6.1%接受PMBR,假体重建最常见(48%)。
  • PMBR患者再入院率略高(3.5% vs 2.8%),但30天和90天死亡率更低。
  • PMBR实施与白人、合并症少、东北部都市区及低肿瘤分期相关(P<.001)。

核心结论

  • PMBR在70岁及以上女性中实施率低,术后死亡率和再入院率总体较低,与年轻患者相当。

研究设计与样本

  • 基于NCDB 2004-2015年数据的回顾性队列分析,纳入73973例70岁及以上接受乳房切除术的乳腺癌患者。

主要发现

  • 4552例(6.1%)行PMBR,其中25%同时行对侧预防性乳房切除术(CPM)。
  • PMBR类型:假体48%,自体组织36.2%,联合重建15.1%。
  • PMBR更常见于白人、合并症少、东北部都市区及低肿瘤分期患者(P<.001)。
  • CPM更常见于白人及南部和西部农村社区医院患者(P<.05)。
  • PMBR患者30天再入院率较高(3.5% vs 2.8%,P<.001),但30天和90天死亡率更低(0.03%和0.2% vs 0.3%和0.9%,P<.001)。

临床怎么用

  • 70岁及以上乳腺癌患者行PMBR术后死亡率和再入院率低,不应仅因年龄排除重建。
  • 需关注PMBR实施中的种族和地理差异,促进公平决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast cancer incidence in women aged ≥70 years is steadily increasing, and many are choosing to undergo postmastectomy breast reconstruction (PMBR). We aimed to identify factors associated with PMBR, describe reconstruction types, and assess postoperative mortality and re-admission rates in women ≥70 years of age. METHODS: The National Cancer Database (NCDB) was examined between 2004 and 2015 for women aged ≥70 years with breast cancer who underwent mastectomy. Statistical analysis was performed by χ2 tests and multivariate logistic regression to select the best models for predicting PMBR and if patients underwent contralateral prophylactic mastectomy (CPM) with reconstruction. RESULTS: A total 73,973 patients met inclusion criteria and 4,552 (6.1%) underwent PMBR, of which 25% had a CPM. 48% had implant reconstruction, 36.2% underwent autologous reconstruction, and 15.1% received combination reconstruction. PMBR was more likely to be performed in patients who were White, had fewer comorbidities, were treated in the Northeast metropolitan areas, and with lower tumor stage (P < .001). CPM was more likely to be performed in patients who were White and treated in community hospitals in rural areas in the South and West. (P < .05). Although 30-day readmission rates were higher in PMBR patients (3.5% vs 2.8%, P < .001), 30 and 90-day mortality rates were lower: 0.03 and 0.2% vs 0.3 and 0.9% (P < .001). CONCLUSION: Although it is understandable that intrinsic tumor characteristics influence the role of PMBR, further research and interventions should be aimed to eliminate the differences that are seen in patient race and geographic location. Readmission and postop mortality rates are overall low and comparable to that of younger patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Cortina CS, Bergom CR, Kijack J, et al. Postmastectomy breast reconstruction in women aged 70 and older: An analysis of the National Cancer Database (NCDB). Surgery. 2021. PMID: 33888316. doi:10.1016/j.surg.2021.03.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。